ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.980
-0.040 (-1.98%)
At close: Mar 13, 2026, 4:00 PM EDT
1.980
0.00 (-0.02%)
After-hours: Mar 13, 2026, 6:23 PM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $260.58 million as of March 13, 2026. Its market cap has increased by 361.74% in one year.
Market Cap
260.58M
Enterprise Value
230.56M
1-Year Change
361.74%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $260.58M, a decrease of -75.33%. That is a compound annual growth rate of -21.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 260.58M | 325.33% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| C4 Therapeutics | 291.76M |
| Context Therapeutics | 291.26M |
| Camp4 Therapeutics | 290.75M |
| Voyager Therapeutics | 289.06M |
| OmniAb | 283.05M |
| Cellectis | 282.07M |
| Inhibikase Therapeutics | 276.30M |
| Cibus | 273.60M |